Redefining Regenerative Medicine with the World’s First Automated Cell Culture System

Overcoming Challenges in Autologous Transplantation through Human-Free Sterilization

While autologous cell banking—storing one's own cells for future medical needs—minimizes rejection risks, high labor costs and shortages have remained significant hurdles. Shibuya has addressed these challenges by combining its expertise in aseptic control and automated transport to develop the world's first system where robots handle cells in a completely isolated "Unmanned Zone." By eliminating human contact, a primary source of contamination, we ensure high-quality and low-cost cell manufacturing while removing the risk of human error.

Transforming Manufacturing with Integrated Robotics and "AMR" Technology

In this advanced system, Autonomous Mobile Robots ("AMR") transport cell samples through AI-optimized processes, interfacing with approximately 100 independent micro-incubators. This setup minimizes stress on sensitive cells caused by impact or temperature changes while automatically recording all manufacturing data. Scheduled for delivery to a new facility for "MEDEZE Group" in Thailand in June 2026, Shibuya aims to lead the industrialization of regenerative medicine, starting in Asia, to make advanced treatments and anti-aging therapies more accessible.